ketanserin has been researched along with Asphyxia in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Asphyxia: A pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, SY | 1 |
| Basura, GJ | 1 |
| Goshgarian, HG | 1 |
1 other study available for ketanserin and Asphyxia
| Article | Year |
|---|---|
Serotonin(2) receptors mediate respiratory recovery after cervical spinal cord hemisection in adult rats.
Topics: Amphetamines; Animals; Asphyxia; Cervical Vertebrae; Female; Ketanserin; Phrenic Nerve; Pyrazines; R | 2001 |